Cornelis M. Van Tilburg, MD, PhD

Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ)
Heidelberg, Baden-Wurttemberg, Germany

Presentation(s):

• Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS

  Thursday, November 17, 2022
  2:08 PM – 2:16 PM

• Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL

  Thursday, November 17, 2022
  2:16 PM – 2:24 PM